Susceptibility to ankylosing spondylitis but not disease outcome is influenced by the level of HLA-B27 expression, which shows moderate variability over time

scientific article published on 24 February 2012

Susceptibility to ankylosing spondylitis but not disease outcome is influenced by the level of HLA-B27 expression, which shows moderate variability over time is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3109/03009742.2011.623138
P698PubMed publication ID22360441

P50authorMatteo PigaQ37829183
Rosa SorrentinoQ41382459
Carlo CarcassiQ48358144
Alessandra VaccaQ59676931
P2093author name stringA Mathieu
A Cauli
M T Fiorillo
G Dessole
G Porru
L Cappai
P P Bitti
P433issue3
P921main subjectrheumatologyQ327657
ankylosing spondylitisQ52849
immunologyQ101929
P304page(s)214-218
P577publication date2012-02-24
P1433published inScandinavian Journal of RheumatologyQ15767622
P1476titleSusceptibility to ankylosing spondylitis but not disease outcome is influenced by the level of HLA-B27 expression, which shows moderate variability over time
P478volume41

Reverse relations

cites work (P2860)
Q28069331A Possible Role of Intestinal Microbiota in the Pathogenesis of Ankylosing Spondylitis
Q38912297Current perspective on the role of the interleukin-23/interleukin-17 axis in inflammation and disease (chronic arthritis and psoriasis).
Q26860818HLA-B27 misfolding and ankylosing spondylitis
Q38266317Killer-cell immunoglobulin-like receptors (KIR) and HLA-class I heavy chains in ankylosing spondylitis.
Q36918422The link between ankylosing spondylitis, Crohn's disease, Klebsiella, and starch consumption

Search more.